Cargando…

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES

Detalles Bibliográficos
Autores principales:	Boerenkamp, L. S., Pothast, C. R., Dijkland, R. C., van Loo, I. H., Wieten, L., Halkes, C. J., Heemskerk, M. H., Van Elssen, C. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431096/ http://dx.doi.org/10.1097/01.HS9.0000849136.47403.f3

Ejemplares similares

P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY
por: Haggenburg, Sabine, et al.
Publicado: (2023)

No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial
por: van Gorkom, Gwendolyn N. Y., et al.
Publicado: (2022)

The English hospital, 1070–1570
por: Wear, Andrew
Publicado: (1998)

Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination
por: Pothast, Cilia R., et al.
Publicado: (2022)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Low Levels of Serum and Intracellular Vitamin C in Hospitalized COVID-19 Patients
por: Boerenkamp, Lara S., et al.
Publicado: (2023)

Blunted humoral response after mRNA vaccine in patients with haematological malignancies
por: Kamboj, Mini
Publicado: (2021)

SARS-CoV-2-specific CD4(+) and CD8(+) T cell responses can originate from cross-reactive CMV-specific T cells
por: Pothast, Cilia R, et al.
Publicado: (2022)

Predicted limited redistribution of T cells to secondary lymphoid tissue correlates with increased risk of haematological malignancies in asplenic patients
por: Kmieciak, Aleksandra E., et al.
Publicado: (2021)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

El gobierno provincial en la Nueva España, 1570-1787 /
Publicado: (2002)

Ordenanzas para el coro de la catedral mexicana 1570
por: Montúfar, Alonso de
Publicado: (1964)

El gobierno provincial en la Nueva España, 1570-1787 /

Price trends of some basic commodities in Central México, 1531-1570 /
por: Borah, Woodrow (Woodrow Wilson), 1912-1999
Publicado: (1958)

Ideas acerca del origen del hombre americano, 1570-1916 /
Publicado: (1987)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
por: van Gelder, Michel, et al.
Publicado: (2016)

1570P Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20
por: Joerger, M., et al.
Publicado: (2021)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
por: Lau, Y S, et al.
Publicado: (2007)

Preferred and actual place of death in haematological malignancy
por: Howell, D A, et al.
Publicado: (2017)

1570 Low rates of virologic failure among previously unmonitored patients in Malawi
por: Rutstein, Sarah E., et al.
Publicado: (2014)

Ultrafast fiber laser at 1570 nm based on organic material as saturable absorber
por: Al-Hiti, Ahmed Shakir, et al.
Publicado: (2022)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies
por: van Rhee, K P, et al.
Publicado: (2022)

Prognosis of patients with haematological malignancies admitted to the ICU
por: Geerse, DA, et al.
Publicado: (2008)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010)

Mononuclear cell-membrane "fluidity": a study in some haematological malignancies.
por: Blecher, T. E., et al.
Publicado: (1977)

Rising incidence of lymphoid malignancies--true or false?
por: Barnes, N., et al.
Publicado: (1986)

Outcome of patients with metastatic cancer or haematological malignancy in intensive care
por: Meynaar, I, et al.
Publicado: (2009)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

Cellular senescence in lymphoid organs and immunosenescence
por: Budamagunta, Vivekananda, et al.
Publicado: (2021)

Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies
por: Ribeiro Baptista, J.P., et al.
Publicado: (2022)

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
por: Hofsink, Quincy, et al.
Publicado: (2023)

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
por: Van Elssen, Catharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_089qgg8ndppjf82v52mfnr682n